This may have been addressed previously, but given the languishing share price, how would a phase 2 trial be funded? PTX doesn't currently have the money for it. Surely the only option currently is a very dilutive capital raise. I can't see "Big Pharma" just throwing them a big pile of cash. Maybe if the trial is approved then the SP jumps and the dilution will be minimal. Thanks.
